GPBAR1 and metabolic disease: Further, we hypothesized that GUDCA may provide a new target and intervention strategy for the prevention and treatment of obesity and related metabolic diseases by regulating the TLCA-B.vulgatus-adipose TGR5 signaling pathway to promote adipose thermogenesis and improve glucolipid metabolism.